Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

8,028 Conversion of warrants by ThromboGenics Ltd 894 894 Contribution in kind Thrombogenics Ltd shares 894 (894) Exchange rate differences as a result of retranslation of foreign subsidiary 4 4 Share based payments 304 304 Fair-Value Adjustment Investments (58) (58) Balance sheet at 30 Jun 2008 (38,026) 67,607 - 67,607 In '000 Euro - Share Share Cumulative Other According to capital premium translation reserves IFRS differences Balance sheet 111,338 15,837 28 (20,851) at 31 Dec. 2008 Net result 2009 Conversion of 2,783 warrants by ThromboGenics Ltd Contribution in 2,488 (2,488) kind Thrombogenics Ltd shares Conversion of 171 70 warrants by ThromboGenics NV Exchange rate 11 differences as a result of retranslation of foreign subsidiary Share based 249 payments Fair-Value 72 Adjustment Investments Balance sheet 113,997 15,907 39 (20,235) at 30 Jun 2009 In '000 Euro - Retained Attributable Minority Total According to IFRS earnings to shareholders interests of the company Balance sheet at 31 Dec. 2008 (43,959) 62
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 News Facts ... India devoted to genome-based research for human health ... is taking a bite out of oral cancer with ... in India with the help of ... DataDirect Networks (DDN). , To fuel its cutting-edge cancer ...
(Date:9/23/2014)... , September 23, 2014 ... Closed System Transfer     Devices  (CSTD) ... partnership with Taiwanese distributor MedFront Medical Technology Corporation.  Equashield,s leading ... Taiwan , China ... the company continues to expand globally, and throughout ...
(Date:9/23/2014)... 2014 The Minnesota High Tech ... cellular modems , platforms and application-specific remote ... category for the 2014 Tekne Awards. The ... Minneapolis Convention Center on Thursday, November 13th. The ... have shown superior technology innovation and leadership. ...
(Date:9/22/2014)... DUBLIN , September 22, 2014 ... has announced the addition of the "Global ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... are added to a system to detect and ... Reagents are generally used in laboratories to prepare, ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... Oconomowoc-based IT services provider, announced Tuesday a new market ... July 1, the campaign will expand the PDS presence ... recently received Specialized Technology Partner Certifications from Cisco in ... partner; IP Communications, IP Communications Express, and Wireless. In ...
... When Hurricane Dennis reached landfall in the Florida ... surprising a development. Weather Central Inc. , a ... almost the exact location two days earlier. , ,On ... a service used by more than 100 television stations ...
... incubates a branding process, which can result in a random ... extreme name identity, whereupon a major advertising process kicks in. ... that's how we refer to today's trendy branding. To avoid ... various branding tricks and become aware of the bigger risks. ...
Cached Biology Technology:Accidental naming 2Accidental naming 3Accidental naming 4
(Date:9/23/2014)... California , 23 de septiembre de ... lanzamiento del Sistema 1290 Infinity II LC, ... de Infinity en su portafolio de cromatografía ... científicos y directores de laboratorio que alcancen ... excepcional, facilidad de uso y capacidad de ...
(Date:9/22/2014)... A new American Cancer Society study suggests that ... previously known as the food stamp program, had ... non-participants. The authors say the findings emphasize the ... dietary quality of SNAP participants. , The SNAP ... with the resources to obtain a nutritionally adequate ...
(Date:9/22/2014)... also known as tapioca, has large starch-filled roots and ... Asia, and Latin America where corn and sugarcane are ... and processes designed to break down tapioca starch into ... such as glucose, fructose, or maltose syrup, tapioca may ... a Review article in Industrial Biotechnology , a ...
Breaking Biology News(10 mins):Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 2Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 3Federal food program puts food on the table, but dietary quality could be improved 2
... menstruating have a weakening in the quality of their bone ... getting plenty of weight-bearing exercise, a new study finds. The ... Annual Meeting in Boston. "Given the high number of ... fact that up to 24% of young female athletes may ...
... Using the only microscope of its kind in Australia, ... see the inner workings of T-cells, the front-line troops that ... germs and other invaders in our bloodstream. The discovery ... T-cells into action a breakthrough that could lead to ...
... 2011 The International Development Research Centre (IDRC) together with ... Sciences and Engineering Research Council of Canada (NSERC), and ... (SSHRC) today announce that five research teams have been ... International Research Initiative on Adaptation to Climate Change (IRIACC). ...
Cached Biology News:Athletic girls more likely to have impaired bone structure if menstrual cycle stops 2Scientists use super microscope to pinpoint body’s immunity 'switch' 2International research initiative on adaptation to climate change announces research awards 2International research initiative on adaptation to climate change announces research awards 3
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Anti-ADAM-12 (Meltrin Alpha); carboxy terminal end; rabbit host...
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
Biology Products: